Mibezit 10,0 mg TABLET
PDF Leaflet Revision Date: 13 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunctive therapy for primary hypercholesterolaemia.
Dosage (summary)
10 mg once daily, with or without food.
Special Populations
- Elderly
- Hepatic impairment
- Paediatric patients 10 years and older
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; safety not established.
Key Drug Interactions
- Bile acid sequestrants
- Fenofibrate
- Warfarin
Contraindications
- Hypersensitivity
- Pregnancy
- Lactation
- Children under 10
- Moderate to severe hepatic impairment
Common side effects
- Headache
- Abdominal pain
- Diarrhoea
- Flatulence
- Myalgia
- Fatigue
Counselling Points
- Take at the same time each day
- Report unexplained muscle pain
- Monitor liver function tests if on statins
Serious warnings
- Risk of myopathy and rhabdomyolysis
- Liver enzyme elevations
Important Disclaimer
The Mibezit 10,0 mg TABLET professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
